| Business: |
(Incorporated in the Cayman Islands)
We, through our operating subsidiaries in China, primarily are engaged in the business of the manufacture and distribution of urology medical devices and care products as well as sales and distribution of cardiovascular and cerebrovascular medical devices.
Our key urology medical device products are as follows and they are classified as Class II medical devices and approved for distribution and sale in China:
1: Guide Wire: A medical device used for urological surgery and diagnosis, mainly used to guide other instruments (such as uteroscopes, stent tubes, etc.) into the urinary tract;
2. Catheter Sheath: A medical device used in urological surgery, mainly used to establish a catheter during endoscopic surgery, facilitating the entry of endoscopes and other instruments into the urinary tract, and for
3. PTA Balloon Catheter: Mainly used for percutaneous transluminal angioplasty of ureteral stricture, or for uteral dilation before ureteroscopy or stone manipulation.
Our key urology care products include Shenni Oil Antimicrobial Wet Wipes, Shenni Oil Antimicrobial Spray, and Shenni Oil Feminine Intimate Care Liquid are a range of products designed for the cleaning and care of both men and women’s intimate hygiene.
Our customers are pharmaceutical and device distributors, pharmacies and hospitals.
|
●
|
Distributors and pharmacies: they are large distributors who we directly cooperate with, such as pharmaceutical and medical device distribution companies, including Huarun Jiangxi Pharmaceutical Co., Ltd, Sinopharm Holding Jiangxi Medical Device Supply Chain Co., Ltd, Sinopharm Holding Ganzhou Medical Trade Co., Ltd, and Sinopharm Holding Jiangxi Co., Ltd. We also sell to the large chain pharmacies in China, such as:
|
|
●
|
Hospitals: we sell to public hospitals of grade 3 or above in all provinces (autonomous regions), municipalities, and directly administered municipalities in China, as well as major private medical groups across the country.
|
Note: Net income and revenue are for the 12 months that ended Sept. 30, 2024.
(Note: Shenni Holdings Ltd. filed its F-1 on March 14, 2025, and disclosed the terms for its IPO: 3.0 million shares at a price range of $4.00 to $6.00 to raise $15.0 million.)
|
